MedTrace Logo

Photobiomodulation Therapy on Pain and Range of Motion Following Flexor Tendon Repair

NCT06761950 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2025-01-07

No results posted yet for this study

Summary

The purpose of the study was to evaluate the therapeutic effect of low-level laser in improving pain and ROM following flexor tendon repair surgery.

Conditions

  • Photobiomodulation Therapy
  • Low Level Laser Therapy
  • Flexor Tendon Rupture
  • Flexor Tendon Repair

Interventions

DEVICE

Low Level laser therapy

The patient received low-level laser therapy three times per week for four weeks, with immobilization maintained. The Mustang 2000 Laser device was used with an infrared laser probe to accelerate tendon healing. The device's specifications include peak power output of 15W, power density of 15W/cm2, wave length of 890nm, pulse frequency of 100Hz, spherical size of 0.002cm2, pulse duration of 130 ns, exposure duration of 60 sec, and energy density of 5.85J/cm2.

DEVICE

Placebo low level laser therapy

Same as in the study group except turning on the device with covering probe by aluminum foil and ask patient to wear sun glasses to obtain the placebo effect 3 sessions per week for 4 weeks.

OTHER

medical treatment

the patients received their drugs from their treating physicians

OTHER

physical therapy program

patients received the traditional program after flexor tendon repair involving isometric exercise, stretching and mobilizations

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2024-11-01
Completion
2024-12-25

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06761950 on ClinicalTrials.gov